SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Marshall NS, Wong KK, Liu PY et al. Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep 2008; 31: 107985.
  • 2
    Young T, Finn L, Peppard PE et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 2008; 31: 10718.
  • 3
    Crummy F, Piper AJ, Naughton MT. Obesity and the lung: 2. Obesity and sleep-disordered breathing. Thorax 2008; 63: 73846.
  • 4
    Saryal S, Celik G, Karabiyikoglu G. Distinctive features and long-term survival of reversible and chronic hypercapnic patients with COPD. Monaldi. Arch. Chest. Dis. 1999; 54: 21216.
  • 5
    Kawata N, Tatsumi K, Terada J et al. Daytime hypercapnia in obstructive sleep apnea syndrome. Chest 2007; 132: 18328.
  • 6
    Laaban JP, Chailleux E. Daytime hypercapnia in adult patients with obstructive sleep apnea syndrome in France, before initiating nocturnal nasal continuous positive airway pressure therapy. Chest 2005; 127: 71015.
  • 7
    Jasper HH. The Ten-Twenty electrode system of the International Federation. Electroencephalogr. Clin. Neurophysiol. 1958; 10: 3715.
  • 8
    Rechtschaffen A, Kales A. A Manual of Standardized Terminology, Techniques and Scoring System of Sleep Stages in Human Subjects. Brain Information Service/Brain Research Institute, University of California, Los Angeles, 1968.
  • 9
    AASM. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999; 22: 66789.
  • 10
    Liu PY, Swerdloff RS, Anawalt BD et al. Determinants of the rate and extent of spermatogenic suppression during hormonal male contraception: an integrated analysis. J. Clin. Endocrinol. Metab. 2008; 93: 177483.
  • 11
    Liu PY, Swerdloff RS, Christenson PD et al. Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis. Lancet 2006; 367: 141220.
  • 12
    Birchfield RI, Sieker HO, Heyman A. Alterations in blood gases during natural sleep and narcolepsy: a correlation with the electroencephalographic stages of sleep. Neurology 1958; 8: 10712.
  • 13
    Birchfield RI, Sieker HO, Heyman A. Alterations in respiratory function during natural sleep. J. Lab. Clin. Med. 1959; 54: 21622.
  • 14
    He J, Kryger MH, Zorick FJ et al. Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest 1988; 94: 914.
  • 15
    Partinen M, Jamieson A, Guilleminault C. Long-term outcome for obstructive sleep apnea syndrome patients. Mortality. Chest 1988; 94: 12004.
  • 16
    Yaggi HK, Concato J, Kernan WN et al. Obstructive sleep apnea as a risk factor for stroke and death. NEJM 2005; 353: 203441.
  • 17
    Weitzenblum E, Chaouat A, Charpentier C et al. Sleep-related hypoxaemia in chronic obstructive pulmonary disease: causes, consequences and treatment. Respiration 1997; 64: 18793.
  • 18
    MRCWP. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet 1981; 1: 6816.
  • 19
    Piper A. Obesity hypoventilation syndrome: therapeutic implications for treatment. Expert. Rev. Respir. Med. 2010; 4: 5770.
  • 20
    Marti S, Sampol G, Munoz X et al. Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment. Eur. Respir. J. 2002; 20: 151118.
  • 21
    Lavie P, Herer P, Lavie L. Mortality risk factors in sleep apnoea: a matched case-control study. J. Sleep Res. 2007; 16: 12834.
  • 22
    Lavie P, Herer P, Peled R et al. Mortality in sleep apnea patients: a multivariate analysis of risk factors. Sleep 1995; 18: 14957.